Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-15

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate whether compound amino acid supplementation can further promote protein synthesis and improve nutritional status for lung cancer patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma

NCT02603016

Lung Neoplasms Breast Neoplasms

COMPLETED NA

Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung Cancer

NCT03673657

Local Advanced Non-small Cell Lung Cancer

COMPLETED PHASE2

Nutritional Supplementation in Patients With Chronic Respiratory Disease

NCT06112730

Chronic Lung Disease

RECRUITING NA

Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients

NCT01136083

Non-small-cell Lung Cancer

COMPLETED NA

Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma

NCT03641105

Lung Cancer Glycolysis Diagnosis +1 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amino Acid Deficiency Malnutrition Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention group

compound amino acid supplement

Group Type EXPERIMENTAL

amino acid tablet

Intervention Type DIETARY_SUPPLEMENT

multiple essential amino acids supplements

control group

placebo

Group Type PLACEBO_COMPARATOR

amino acid tablet

Intervention Type DIETARY_SUPPLEMENT

multiple essential amino acids supplements

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

amino acid tablet

multiple essential amino acids supplements

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* NRS2002 \>=3 scores
* lung cancer patients
* low albumin or hemoglobin
* informed consent

Exclusion Criteria

* Acute and critical patients;
* Severe liver and kidney dysfunction;
* Patients with gastrointestinal bleeding or intestinal obstruction;
* Pregnant women, lactating women, people with mental illness, and people without independent behavior ability.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No